日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

非小细胞肺癌软脑膜转移的演变格局:一项国际性、当代、多中心队列研究

Zheng, M M; Xia, Y; Pan, K; Sun, F; Tan, A C; Dong, X R; Tu, H Y; Tang, L B; Li, Y S; Yin, K; Borgeaud, M; Singhal, S; Zhu, E; Zhang, J; Nilsson, M; Wu, J; Gibbons, D L; Wakelee, H; Neal, J W; Lee, J; Vaporciyan, A A; Ringsurongkawong, W; Tran, H T; Zhang, R Z; Zhang, T; Zhou, Q; Zhong, W Z; Li, W; Zhang, Y C; Riess, J W; Addeo, A; Heymach, J V; Myall, N; Tan, D; Wu, Y L; Le, X

Global advances and future directions in lung cancer care: expert consensus and strategic priorities

全球肺癌治疗进展及未来方向:专家共识和战略重点

Meyer, M-L; Peters, S; Jänne, P A; Mok, T S; Bunn, P A; Abdel Karim, N; Altorki, N K; Arrieta, O; Bar, J; Cappuzzo, F; Carbone, D; Dacic, S; Diehn, M; Dziadziuszko, R; Felip, E; Flores, R; Florez, N; Forde, P M; Gainor, J F; Gray, J E; Gros, L; Halmos, B; Henschke, C I; Herbst, R; Heymach, J V; Kelly, K; Kris, M G; Leighl, N B; Mathias, C; Marron, T U; Mulshine, J L; Naidoo, J; Osarogiagbon, R; Passaro, A; Peled, N; Planchard, D; Politi, K; Popat, S; Pyenson, B; Reckamp, K L; Ren, S H; Riely, G J; Rolfo, C; Rudin, C M; Sen, T; Shields, M D; Singh, H; Skoulidis, F; Solomon, B J; Stahel, R; Stiles, B M; Syrigos, K; Yang, J C-H; Yang, P-C; Wolf, A; Wozniak, A J; Waqar, S N; Wakelee, H; Hirsch, F R

Treatment options and considerations for acquired resistance in EGFR mutation-positive non-small-cell lung cancer

EGFR突变阳性非小细胞肺癌的治疗选择及获得性耐药的考量

Le, X; Popat, S; Heymach, J V; West, H; Zhang, L

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS(G12C) inhibitors

具有黏液性组织学特征的肺腺癌:临床、基因组和免疫微环境特征以及基于免疫疗法和KRAS(G12C)抑制剂的治疗结果

Di Federico, A; Hong, L; Elkrief, A; Thummalapalli, R; Cooper, A J; Ricciuti, B; Digumarthy, S; Alessi, J V; Gogia, P; Pecci, F; Makarem, M; Gandhi, M M; Garbo, E; Saini, A; De Giglio, A; Favorito, V; Scalera, S; Cipriani, L; Marinelli, D; Haradon, D; Nguyen, T; Haradon, J; Voligny, E; Vaz, V; Gelsomino, F; Sperandi, F; Melotti, B; Ladanyi, M; Zhang, J; Gibbons, D L; Heymach, J V; Nishino, M; Lindsay, J; Rodig, S J; Pfaff, K; Sholl, L M; Wang, X; Johnson, B E; Jänne, P A; Rekhtman, N; Maugeri-Saccà, M; Heist, R S; Ardizzoni, A; Awad, M M; Arbour, K C; Schoenfeld, A J; Vokes, N I; Luo, J

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer

循环肿瘤DNA和放射学肿瘤体积可识别接受切除术的早期非小细胞肺癌患者中复发的风险。

Tran, H T; Heeke, S; Sujit, S; Vokes, N; Zhang, J; Aminu, M; Lam, V K; Vaporciyan, A; Swisher, S G; Godoy, M C B; Cascone, T; Sepesi, B; Gibbons, D L; Wu, J; Heymach, J V

Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma

KRAS突变型肺腺癌转移性疾病的分子标志物

Boiarsky, D; Lydon, C A; Chambers, E S; Sholl, L M; Nishino, M; Skoulidis, F; Heymach, J V; Luo, J; Awad, M M; Janne, P A; Van Allen, E M; Barbie, D A; Vokes, N I

Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results

在既往未接受治疗的EGFR突变转移性非小细胞肺癌患者中,雷莫芦单抗联合厄洛替尼与安慰剂联合厄洛替尼的疗效比较(RELAY):二代测序结果的探索性分析

Garon, E B; Reck, M; Nishio, K; Heymach, J V; Nishio, M; Novello, S; Paz-Ares, L; Popat, S; Aix, S Ponce; Graham, H; Butts, B D; Visseren-Grul, C; Nakagawa, K

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

不同的肿瘤浸润淋巴细胞分布与局限性非小细胞肺癌的临床结果相关

Federico, L; McGrail, D J; Bentebibel, S-E; Haymaker, C; Ravelli, A; Forget, M-A; Karpinets, T; Jiang, P; Reuben, A; Negrao, M V; Li, J; Khairullah, R; Zhang, J; Weissferdt, A; Vaporciyan, A A; Antonoff, M B; Walsh, G; Lin, S-Y; Futreal, A; Wistuba, I; Roth, J; Byers, L A; Gaudreau, P-O; Uraoka, N; Cruz, A F; Dejima, H; Lazcano, R N; Solis, L M; Parra, E R; Lee, J J; Swisher, S; Cascone, T; Heymach, J V; Zhang, J; Sepesi, B; Gibbons, D L; Bernatchez, C

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS(G12D)-mutated non-small-cell lung cancer

剖析KRAS(G12D)突变型非小细胞肺癌的临床病理学、基因组学和免疫表型相关性

Ricciuti, B; Alessi, J V; Elkrief, A; Wang, X; Cortellini, A; Li, Y Y; Vaz, V R; Gupta, H; Pecci, F; Barrichello, A; Lamberti, G; Nguyen, T; Lindsay, J; Sharma, B; Felt, K; Rodig, S J; Nishino, M; Sholl, L M; Barbie, D A; Negrao, M V; Zhang, J; Cherniack, A D; Heymach, J V; Meyerson, M; Ambrogio, C; Jänne, P A; Arbour, K C; Pinato, D J; Skoulidis, F; Schoenfeld, A J; Awad, M M; Luo, J

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study

凡德他尼联合依维莫司治疗晚期实体瘤患者的安全性和疗效:一项 I 期研究

Cascone, T; Sacks, R L; Subbiah, I M; Drobnitzky, N; Piha-Paul, S A; Hong, D S; Hess, K R; Amini, B; Bhatt, T; Fu, S; Naing, A; Janku, F; Karp, D; Falchook, G S; Conley, A P; Sherman, S I; Meric-Bernstam, F; Ryan, A J; Heymach, J V; Subbiah, V